NKTX Nkarta Inc

Price (delayed)

$2.765

Market cap

$197.82M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.34

Enterprise value

$242.72M

?
Relative Growth: Rel. Growth: 9
Relative Strength: Rel. Strength: 77
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 12

Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic, off the shelf natural killer (NK) cell therapies for cancer. By combining its cell expansion and cryopreservation platform with ...

Highlights
NKTX's EPS is up by 11% year-on-year and by 5% since the previous quarter
Nkarta's net income has increased by 10% YoY and by 4% QoQ
NKTX's quick ratio is down by 10% year-on-year but it is up by 2.2% since the previous quarter
Nkarta's equity has decreased by 25% YoY and by 8% QoQ

Key stats

What are the main financial stats of NKTX

NKTX stock price

How has the Nkarta stock price performed over time
Intraday
1.65%
1 week
-16.21%
1 month
-8.44%
1 year
46.3%
YTD
49.46%
QTD
31.04%

Financial performance

How have Nkarta's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$116.31M
Net income
-$99.93M
Gross margin
N/A
Net margin
N/A
Nkarta's operating income has increased by 12% YoY and by 4.7% from the previous quarter
Nkarta's net income has increased by 10% YoY and by 4% QoQ

Price vs fundamentals

How does NKTX's price correlate with its fundamentals

Growth

What is Nkarta's growth rate over time

Valuation

What is Nkarta stock price valuation
P/E
N/A
P/B
0.69
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
NKTX's EPS is up by 11% year-on-year and by 5% since the previous quarter
The P/B is 70% above the last 4 quarters average of 0.4 but 38% below the 5-year quarterly average of 1.1
Nkarta's equity has decreased by 25% YoY and by 8% QoQ

Efficiency

How efficient is Nkarta business performance
NKTX's return on equity is down by 16% year-on-year and by 3% since the previous quarter
The ROA has contracted by 12% YoY
NKTX's return on invested capital is down by 9% year-on-year

Dividends

What is NKTX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NKTX.

Financial health

How did Nkarta financials performed over time
NKTX's total assets is down by 21% YoY and by 8% QoQ
NKTX's quick ratio is down by 10% year-on-year but it is up by 2.2% since the previous quarter
NKTX's debt is 74% smaller than its equity
Nkarta's equity has decreased by 25% YoY and by 8% QoQ
NKTX's debt to equity is up by 24% year-on-year and by 8% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.